Top Markets
#1 Siacoin Siacoin +33.02%
#2 Official Trump Official Trump +23.94%
#3 EXOD EXOD +18.93%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +18.60%
#5 MowCat MowCat +17.88%
#6 Melania Meme Melania Meme +17.83%
#7 Unit Pump Unit Pump +16.67%
#8 Pump.fun Pump.fun +16.67%
#9 Siren Siren +14.85%
#10 The Bitcoin Bull The Bitcoin Bull +14.83%
Coin of the day
Siacoin Siacoin
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Annovis Bio, Inc. Annovis Bio, Inc.

Annovis Bio, Inc.

ANVS
Classificação em ações #23205
Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on... Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for neurodegenerative disorders. The firm's flagship drug, Buntanetap, an oral medication, has successfully advanced through Phase 2a clinical trials for Alzheimer's and Parkinson's diseases. This compound is also currently being evaluated in clinical studies for Alzheimer's disease in individuals with Down Syndrome, as well as for various other chronic neurodegenerative conditions. Beyond Buntanetap, Annovis Bio is developing ANVS405 to offer protection against traumatic brain injury and stroke. Additionally, ANVS301 is progressing through Phase I clinical trials, aiming to enhance cognitive capabilities in the later stages of Alzheimer's disease and broader dementia. The company was founded in 2008 and operates out of Berwyn, Pennsylvania.
Preço da ação
$1.81
Última sincronização: 2026-08-21
Valor de mercado
$77.00M
Variação (1 dia)
1.30%
Variação (1 ano)
-23.63%
País
US
Negociar Annovis Bio, Inc. (ANVS)

Categoria

Healthcare
Lucros da Annovis Bio, Inc. (ANVS)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Annovis Bio, Inc., os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Annovis Bio, Inc. de 2026 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
Não há dados suficientes para as datas fornecidas.
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH